Our Team.

 
Jim Monsor   Jim has more than 35 years of experience in drug, device, and biologic development and commercialization. Executive leadership with startups and strategic partnerships. Background in operations, product development, quality and regulatory.

Jim Monsor

Jim has more than 35 years of experience in drug, device, and biologic development and commercialization. Executive leadership with startups and strategic partnerships. Background in operations, product development, quality and regulatory.

Jim Monsor

Chief Executive Officer

Robert Hoffman, M.D.   Robert has more than 40 years of experience as an Ophthamologist, internationally recognized clinician, teacher, inventor, scientist and author.

Robert Hoffman, M.D.

Robert has more than 40 years of experience as an Ophthamologist, internationally recognized clinician, teacher, inventor, scientist and author.

ROBERT HOFMANN, M.D.

Chief Scientific Officer

Mark Henschen, M.B.A.   Mark has more than 35 years of experience in the financial industry serving as CEO and President of an institutional bank. He also holds his CFP certification.

Mark Henschen, M.B.A.

Mark has more than 35 years of experience in the financial industry serving as CEO and President of an institutional bank. He also holds his CFP certification.

Mark Henschen, M.B.A.

Chief Financial Officer

Gordon Phillips, M.B.A.   Gordon has nine years of experience in the healthcare industry with a focus on finance. He has experience with CVS Caremark and Raymond James Healthcare Investment Banking as well as an MBA from the Wharton School.

Gordon Phillips, M.B.A.

Gordon has nine years of experience in the healthcare industry with a focus on finance. He has experience with CVS Caremark and Raymond James Healthcare Investment Banking as well as an MBA from the Wharton School.

Gordon Phillips, M.B.A.

VP of Finance

Mitchell Brooks, M.D.   Mitchell has more than 35 years of experience as an orthopedic surgeon, healthcare strategy consultant, patient advocate, and healthcare entrepreneur.

Mitchell Brooks, M.D.

Mitchell has more than 35 years of experience as an orthopedic surgeon, healthcare strategy consultant, patient advocate, and healthcare entrepreneur.

Mitchell Brooks, M.D.

VP of Strategy

Marcus Henschen, R.N.   Marcus has eight years of experience in clinical practice. His background is in healthcare and medical device startups as well as healthcare IT consulting and business development.

Marcus Henschen, R.N.

Marcus has eight years of experience in clinical practice. His background is in healthcare and medical device startups as well as healthcare IT consulting and business development.

MARCUS HENSCHEN, RN

VP of Business Development

Josh Niemeyer   Josh has five years of experience in residential and advertising business dev and deal making. He has worked for Lamar advertising and a real estate investment trust based in Ohio.

Josh Niemeyer

Josh has five years of experience in residential and advertising business dev and deal making. He has worked for Lamar advertising and a real estate investment trust based in Ohio.

Josh Niemeyer

Business Development Associate

blue-block.png

Interested In Joining The Team?

Shoot us a message with how you think you can contribute.

 

Advisory Board.

RUSSEL PAGANO, PH.D

Russ has over 20 years of experience in the medical device/biologics industry.  Russ joined Biomimetic Therapeutics in 2007 as Vice President, Clinical and Regulatory Affairs, and served in that role until January 2016. During that time he led the drive to the first approval of a combination device/biologic  in over ten years.  Prior to BioMimetic, he cofounded a clinical and regulatory consulting company based in Washington DC. Russ started his career working 7 years for the FDA, overseeing device filing reviews and product approvals.

GEORGE DUNBAR

George has extensive healthcare and life sciences operating experience, and has served as an advisor, Director, or CEO with private and public companies in diagnostics, specialty pharma, cell therapy, and biologics. He is the managing partner of The Dunbar Group providing management services to the life sciences. The most recent  assignment was CEO of  Isto Biologics, Prior to ISTO Technologies, he served as a Venture Partner with Arboretum Ventures, and a director of four portfolio life science companies - two as executive chairman. He has held senior leadership positions with Ares-Serono (now Merck-Serono) and Amersham International (now GE Healthcare).

STAYKO STAYKOV

Stayko has over fifteen years of experience in entrepreneurship, strategic asset management and advising in the areas of strategy development, mergers & acquisitions, intellectual property assets, technology licensing, and leadership development. He is also co-founder of Venture Grove and a director for Zyxogen.